NEW DELHI: India's pharmaceuticals sector has received FDI of $1 billion, the highest among the top 10 segments, during the April-June period this year amid concerns over increasing acquisitions of domestic firms by multinationals.
Foreign Direct Investment (FDI) in drugs and pharmaceuticals during April-June 2012 stood at $465 million, according to the latest data of department of industrial policy and promotion (DIPP).
The DIPP is working on a cabinet note to include major changes in the FDI policy in the sector to protect domestic generic (off-patent) firms.
0 comments:
Post a Comment